resonance spectroscopy signal in vivo. J. Neurochem. 74, 254 –
262.
Birken D. L. and Oldendorf W. H. (1989) N-Acetyl-L-aspartic acid: a
literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23–31.
Burlina A. P., Corazza A., Ferrari V., Erhard P., Kunnecke B., Seelig
J., and Burlina A. B. (1994) Detection of increased urinary
N-acetylaspartylglutamate in Canavan disease. Eur. J. Pediatr.
153, 538 –539.
Cassidy M. and Neale J. H. (1993) Localization and transport of
N-acetylaspartylglutamate in cells of whole murine brain in primary culture. J. Neurochem. 60, 1631–1638.
Coyle J. T. (1997) The nagging question of the function of N-acetylaspartylglutamate. Neurobiol. Dis. 4, 231–238.
Davies D. G., Parsek M. R., Pearson J. P., Iglewski B. H., Costerton
J. W., and Greenberg E. P. (1998) The involvement of cell-to-cell
signals in the development of a bacterial biofilm. Science 280,
295–298.
Elpeleg O. N. and Shaag A. (1999) The spectrum of mutations of the
aspartoacylase gene in Canavan disease in non-Jewish patients.
J. Inherit. Metab. Dis. 22, 531–534.
Froes M. M. and Campos De Carvalho A. C. (1998) Gap junctionmediated loops of neuronal– glial interactions. Glia 24, 97–107.
Hess W. R. (1997) Localization of an open reading frame with homology to human aspartoacylase upstream from psbA in the prokaryote Prochlorococcus marinus CCMP 1375. DNA Seq. J. Seq.
Map. 7, 301–306.
Hohmann C. F. and Berger-Sweeney J. (1998) Cholinergic regulation
of cortical development and plasticity. New twists to an old story.
Perspect. Dev. Neurobiol. 5, 401– 425.
Inoue H., Sawada M., Ryo A., Tanahashi H., Wakatsuki T., Hada A.,
Kondoh N., Nakagaki K., Takahashi K., Suzumura A., Yamamoto
M., and Tabira T. (1999) Serial analysis of gene expression in a
microglial cell line. Glia 28, 265–271.
Kaul R., Casanova J., Johnson A. B., Tang P., and Matalon R. (1991)
Purification, characterization, and localization of aspartoacylase
from bovine brain. J. Neurochem. 56, 129 –135.
Leone P., Janson C. G., McFhee S. J., and During M. J. (1999) Global
CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease. Curr. Opin. Mol. Ther. 1, 487– 492.
Leshinsky E., Ribeiro L., Gage D. A., and Kolodny E. H. (1997)
N-Acetyl aspartoglutamate metabolism in brain: application to
Canavan disease. (Abstr.) J. Neurochem. 69 (Suppl.), S192A.
Luthi-Carter R., Berger U. V., Barczak A. K., Enna M., and Coyle J. T.
(1998) Isolation and expression of a rat brain cDNA encoding
glutamate carboxypeptidase II. Proc. Natl. Acad. Sci. USA 95,
3215–3220.
Marks N. and Berg M. J. (1999) Recent advances on neuronal caspases
in development and neurodegeneration. Neurochem. Int. 35, 195–
220.
Matalon R. (1997) Canavan disease: diagnosis and molecular analysis.
Genet. Test. 1, 21–25.
Matalon R., Michals K., Sebasta D., Deanching M., Gashkoff P., and
Casanova J. (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet.
29, 463– 471.
Passani L., Elkabes S., and Coyle J. T. (1998) Evidence for the
presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia. Brain Res. 794, 143–145.
